Results of the review also found that 18 adverse events occurred in a total of 13 patients (18.1% of patients; 6.6% of infusions). For pediatric patients with inflammatory bowel disease (IBD), ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, ...

The most frequent haematological problem identified during pregnancy is anemia. The World Health Organization defines anemia ...

Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...

Amphastar has received permission from the Food and Drug Administration for iron sucrose injection, 50mg/2.5ml, 100mg/5ml and 200mg/10ml in single-dose vials, previously referred to as AMP-002. Iron ...

Iron Sucrose (Feroject) is a mineral iron, prescribed for iron deficiency anemia especially for kidney failure patients. It replenishes body iron stores in patients with iron deficiency. The ...

Iron repletion is a very common and necessary therapy for patients with NDDCKD. Oral iron supplementation is frequently not tolerated and sometimes inadequate to replete the body's iron stores. The ...

Iron Sucrose is a mineral iron, prescribed for iron deficiency anemia especially for kidney failure patients. Aloglutamol can cause a decrease in the absorption of Iron saccharate resulting in a ...

A total of 100 patients were identified as receiving at least one 300-mg dose of elemental iron i.v. as iron sucrose. Of these patients, 73 had NDDCKD; the remaining 27 patients had a CL cr of ≥60 ...